Author:
Mhaidat Nizar M.,Qandil Amjad M.,Al-Balas Qosay A.,Hassan Mohammad A.,Jaradat Saied A.,Matalkah Ahmad M.,Thorne Rick T.
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference31 articles.
1. Anderson, V.A., and N. Osheroff. 2001. Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde. Current Pharmaceutical Design 7: 339–355.
2. Appelbaum, P.C., and P.A. Hunter. 2000. The fluoroquinolone antibacterials: Past, present and future perspectives. International Journal of Antimicrobial Agents 16: 5–15.
3. Aranha, O., R. Grignon, N. Fernandes, T.J. McDonnell, D.P. Wood Jr, and F.H. Sarkar. 2003. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. International Journal of Oncology 22: 787–794.
4. Aranha, O., D.P. Wood Jr, and F.H. Sarkar. 2000. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clinical Cancer Research 6: 891–900.
5. Ashkenazi, A., and V.M. Dixit. 1998. Death receptors: Signaling and modulation. Science 281: 1305–1308.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献